Practical use of dabigatran etexilate for stroke prevention in atrial fibrillation

Atrial fibrillation (AF) is associated with an increased risk of thromboembolism, and is the most prevalent factor for cardioembolic stroke. Vitamin K antagonists (VKAs) have been the standard of care for stroke prevention in patients with AF since the early 1990s. They are very effective for the pr...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Huber, K, Connolly, S J, Kher, A, Christory, F, Dan, G-A, Hatala, R, Kiss, R G, Meier, B, Merkely, B, Pieske, B, Potpara, T, Stępińska, J, Klun, N Vene, Vinereanu, D, Widimský, P
Формат: Artigo
Язык:Inglês
Опубликовано: Blackwell Publishing Ltd 2013
Предметы:
Cardiovascular
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC3712459/
https://ncbi.nlm.nih.gov/pubmed/23557519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/ijcp.12147
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы